Liquidia Corporation (NASDAQ:LQDA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ten analysts that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have given a buy recommendation and three have issued a strong buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $67.4286.
A number of equities analysts have recently issued reports on the company. Raymond James Financial reissued a “strong-buy” rating and issued a $68.00 target price on shares of Liquidia in a report on Thursday, June 4th. Oppenheimer set a $75.00 price target on shares of Liquidia in a research report on Friday, June 5th. Wells Fargo & Company boosted their price target on shares of Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a research report on Tuesday, May 12th. BTIG Research boosted their price target on shares of Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a research report on Monday. Finally, Wall Street Zen upgraded shares of Liquidia from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 16th.
View Our Latest Analysis on Liquidia
Liquidia Trading Up 2.0%
Liquidia (NASDAQ:LQDA – Get Free Report) last issued its earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $119.44 million. The firm’s revenue was up 4187.1% on a year-over-year basis. On average, sell-side analysts predict that Liquidia will post 2.97 EPS for the current fiscal year.
Insider Buying and Selling
In related news, Director Stephen M. Bloch sold 100,000 shares of the stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $75.74, for a total transaction of $7,574,000.00. Following the sale, the director directly owned 880,073 shares in the company, valued at $66,656,729.02. This represents a 10.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sanjeev Khindri sold 4,134 shares of the stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $65.46, for a total value of $270,611.64. Following the sale, the insider owned 67,132 shares in the company, valued at approximately $4,394,460.72. This trade represents a 5.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 2,364,580 shares of company stock worth $135,244,941 in the last three months. Insiders own 25.60% of the company’s stock.
Institutional Investors Weigh In On Liquidia
A number of large investors have recently bought and sold shares of the business. Seven Fleet Capital Management LP grew its position in Liquidia by 124.5% during the 1st quarter. Seven Fleet Capital Management LP now owns 204,876 shares of the company’s stock worth $7,732,000 after acquiring an additional 113,609 shares during the last quarter. Segall Bryant & Hamill LLC bought a new stake in Liquidia during the 1st quarter worth approximately $2,111,000. Bank of America Corp DE grew its position in Liquidia by 18.7% during the 1st quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after acquiring an additional 360,372 shares during the last quarter. California State Teachers Retirement System boosted its position in Liquidia by 25.0% in the 1st quarter. California State Teachers Retirement System now owns 72,438 shares of the company’s stock valued at $2,734,000 after buying an additional 14,485 shares during the last quarter. Finally, Empowered Funds LLC bought a new position in Liquidia in the 1st quarter valued at $3,650,000. 64.54% of the stock is currently owned by institutional investors.
Liquidia Company Profile
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Read More
- Five stocks we like better than Liquidia
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.
